QC Dashboard - Multi-File Comparison
433 files analyzed (sorted by compliance, lowest first)
Files Analyzed
433
Average Compliance
74.2%
Total Checks
18613/25077
Total Violations
252
Slot Compliance Comparison
Priority Files - Detailed View
Showing the 10 files with lowest compliance for prioritized curation.
#1: Galactosemia.yaml (13.3%)
#2: Ulcerative_Colitis.yaml (36.9%)
#3: Psoriasis.yaml (38.6%)
#4: Celiac_Disease.yaml (41.1%)
#5: Neurofibromatosis_Type_1.yaml (42.9%)
#6: Epilepsy.yaml (43.3%)
#7: Peripheral_Artery_Disease.yaml (44.2%)
#8: Medulloblastoma_WNT_Activated.yaml (44.4%)
#9: Pheochromocytoma_Paraganglioma.yaml (44.4%)
#10: Gastric_Cancer_H_pylori_Associated.yaml (45.3%)
All Files (Sorted by Priority)
Files with lowest compliance are listed first to prioritize curation efforts.
| File | Global | Weighted | Populated | Violations |
|---|---|---|---|---|
#1 Galactosemia.yaml |
13.3% | 4.9% | 4/30 | 1 |
#2 Ulcerative_Colitis.yaml |
36.9% | 45.9% | 31/84 | |
#3 Psoriasis.yaml |
38.6% | 47.3% | 27/70 | |
#4 Celiac_Disease.yaml |
41.1% | 50.8% | 23/56 | |
#5 Neurofibromatosis_Type_1.yaml |
42.9% | 51.0% | 24/56 | 1 |
#6 Epilepsy.yaml |
43.3% | 52.3% | 26/60 | 1 |
#7 Peripheral_Artery_Disease.yaml |
44.2% | 51.7% | 19/43 | |
#8 Medulloblastoma_WNT_Activated.yaml |
44.4% | 53.2% | 20/45 | 1 |
#9 Pheochromocytoma_Paraganglioma.yaml |
44.4% | 53.0% | 24/54 | 1 |
#10 Gastric_Cancer_H_pylori_Associated.yaml |
45.3% | 54.4% | 29/64 | 2 |
HPV_Negative_Head_and_Neck_Cancer.yaml |
45.3% | 53.5% | 29/64 | 2 |
Hashimotos_Thyroiditis.yaml |
45.7% | 55.0% | 21/46 | |
IDH_Mutant_Oligodendroglioma.yaml |
45.8% | 54.3% | 22/48 | 1 |
Aflatoxin_Related_HCC.yaml |
45.9% | 54.6% | 28/61 | 1 |
Glioblastoma_IDH_Wildtype.yaml |
46.2% | 53.9% | 30/65 | 1 |
H3_K27_Altered_Diffuse_Midline_Glioma.yaml |
46.2% | 55.2% | 24/52 | 1 |
Burkitt_Lymphoma.yaml |
46.3% | 56.0% | 25/54 | 1 |
Liver_Cirrhosis.yaml |
46.6% | 55.7% | 27/58 | |
Kaposi_Sarcoma.yaml |
46.7% | 54.7% | 28/60 | 1 |
Malignant_Mesothelioma.yaml |
46.7% | 54.3% | 28/60 | 2 |
Ankylosing_Spondylitis.yaml |
46.8% | 54.1% | 22/47 | |
IDH_Mutant_Astrocytoma.yaml |
46.8% | 56.2% | 22/47 | 1 |
Chronic_Lymphocytic_Leukemia.yaml |
47.0% | 56.8% | 31/66 | 1 |
EBV_Associated_Gastric_Cancer.yaml |
47.1% | 55.8% | 24/51 | 1 |
Primary_Tonsillar_Lymphoma.yaml |
47.1% | 49.6% | 49/104 | 4 |
Cervical_Cancer.yaml |
47.2% | 54.7% | 25/53 | 1 |
IDH_Mutant_AML.yaml |
47.2% | 56.4% | 25/53 | 1 |
Chronic_Kidney_Disease.yaml |
47.3% | 56.5% | 26/55 | |
Atopic_Dermatitis.yaml |
47.3% | 59.8% | 35/74 | 1 |
Nasopharyngeal_Carcinoma.yaml |
47.4% | 55.4% | 27/57 | 2 |
Clear_Cell_Sarcoma.yaml |
47.5% | 56.0% | 19/40 | 1 |
BRCA_Mutant_Prostate_Cancer.yaml |
47.6% | 55.3% | 20/42 | 1 |
Sarcoidosis.yaml |
47.6% | 58.2% | 20/42 | 1 |
Alveolar_Rhabdomyosarcoma.yaml |
47.7% | 56.4% | 21/44 | 1 |
Hereditary_Breast_and_Ovarian_Cancer_Syndrome.yaml |
47.7% | 55.2% | 21/44 | 1 |
Diffuse_Large_B_Cell_Lymphoma.yaml |
47.8% | 57.4% | 32/67 | 1 |
Uveal_Melanoma.yaml |
47.8% | 56.3% | 22/46 | 1 |
Wilms_Tumor.yaml |
47.8% | 57.0% | 22/46 | 1 |
Medulloblastoma_SHH_Activated.yaml |
47.9% | 57.2% | 23/48 | 1 |
Glaucoma.yaml |
48.0% | 55.3% | 24/50 | 1 |
Basal_Cell_Carcinoma.yaml |
48.1% | 56.6% | 26/54 | 1 |
Mantle_Cell_Lymphoma.yaml |
48.4% | 58.2% | 30/62 | 1 |
Autoimmune_Hemolytic_Anemia.yaml |
48.5% | 57.9% | 16/33 | |
MCAD_Deficiency.yaml |
48.5% | 56.4% | 16/33 | 1 |
Dermatofibrosarcoma_Protuberans.yaml |
48.6% | 55.8% | 18/37 | 1 |
Hepatocellular_Carcinoma.yaml |
48.7% | 57.7% | 37/76 | 1 |
Synovial_Sarcoma.yaml |
48.7% | 56.6% | 19/39 | 1 |
Embryonal_Rhabdomyosarcoma.yaml |
48.8% | 57.6% | 20/41 | 1 |
Gout.yaml |
48.8% | 56.8% | 21/43 | |
Gastroesophageal_Reflux_Disease.yaml |
48.9% | 57.1% | 22/45 | |
Obstructive_Sleep_Apnea.yaml |
48.9% | 56.9% | 22/45 | |
NPM1_Mutant_AML.yaml |
48.9% | 58.6% | 23/47 | 1 |
KRAS_G12C_Mutant_NSCLC.yaml |
49.0% | 56.6% | 24/49 | 1 |
Endometriosis.yaml |
49.0% | 57.3% | 25/51 | |
HPV_Positive_Head_and_Neck_Cancer.yaml |
49.1% | 57.8% | 26/53 | 1 |
FLT3_Mutant_AML.yaml |
49.1% | 58.8% | 27/55 | 1 |
Alopecia_Areata.yaml |
50.0% | 55.8% | 15/30 | |
Arsenic_Related_Cancers.yaml |
50.0% | 56.9% | 30/60 | 1 |
Core_Binding_Factor_AML.yaml |
50.0% | 59.7% | 26/52 | 1 |
FGFR_Altered_Urothelial_Carcinoma.yaml |
50.0% | 57.5% | 18/36 | 1 |
Generalized_Anxiety_Disorder.yaml |
50.0% | 60.5% | 27/54 | |
Guillain_Barre_Syndrome.yaml |
50.0% | 58.3% | 16/32 | |
HER2_Positive_Colorectal_Cancer.yaml |
50.0% | 59.0% | 26/52 | 1 |
Heart_Failure.yaml |
50.0% | 58.0% | 23/46 | |
IgA_Nephropathy.yaml |
50.0% | 58.4% | 20/40 | |
KIT_Mutant_Melanoma.yaml |
50.0% | 57.3% | 23/46 | 1 |
Li-Fraumeni_Syndrome.yaml |
50.0% | 56.2% | 25/50 | 1 |
MET_Exon_14_Skipping_NSCLC.yaml |
50.0% | 58.7% | 24/48 | 1 |
NRAS_Mutant_Melanoma.yaml |
50.0% | 57.9% | 18/36 | 1 |
RET_Fusion_Thyroid_Cancer.yaml |
50.0% | 58.0% | 22/44 | 1 |
RET_Rearranged_NSCLC.yaml |
50.0% | 58.4% | 25/50 | 1 |
Bronchiectasis.yaml |
50.6% | 59.3% | 40/79 | 1 |
FGFR_Altered_Cholangiocarcinoma.yaml |
50.8% | 59.7% | 30/59 | 1 |
APL_PML_RARA.yaml |
50.9% | 59.9% | 29/57 | 1 |
Primary_Myelofibrosis.yaml |
50.9% | 60.5% | 29/57 | 1 |
IDH_Mutant_Cholangiocarcinoma.yaml |
50.9% | 59.7% | 27/53 | 1 |
ALK_Rearranged_NSCLC.yaml |
51.0% | 59.6% | 26/51 | 1 |
Merkel_Cell_Carcinoma.yaml |
51.0% | 59.1% | 25/49 | 1 |
Familial_Adenomatous_Polyposis.yaml |
51.1% | 59.3% | 24/47 | 1 |
Age_Related_Macular_Degeneration.yaml |
51.2% | 57.7% | 22/43 | |
BRAF_Mutant_Thyroid_Cancer.yaml |
51.2% | 59.0% | 21/41 | 1 |
PIK3CA_Mutant_Breast_Cancer.yaml |
51.2% | 57.2% | 21/41 | 1 |
Systemic_Sclerosis.yaml |
51.4% | 61.7% | 19/37 | |
Behcets_Disease.yaml |
51.5% | 59.5% | 17/33 | |
Neuroblastoma.yaml |
51.7% | 59.7% | 31/60 | 2 |
HER2_Positive_Gastric_Cancer.yaml |
51.8% | 61.4% | 29/56 | 1 |
Myasthenia_Gravis.yaml |
51.8% | 61.4% | 29/56 | |
Ph_Positive_ALL.yaml |
51.8% | 61.5% | 29/56 | 1 |
Gastrointestinal_Stromal_Tumor.yaml |
51.9% | 60.3% | 28/54 | 1 |
Hypochondroplasia.yaml |
51.9% | 61.1% | 14/27 | 1 |
BRAF_V600E_Mutant_Colorectal_Cancer.yaml |
51.9% | 60.4% | 27/52 | 1 |
ROS1_Rearranged_NSCLC.yaml |
51.9% | 60.2% | 27/52 | 1 |
EGFR_Mutant_NSCLC.yaml |
52.0% | 60.3% | 26/50 | 1 |
Multiple_Endocrine_Neoplasia_Type_2.yaml |
52.1% | 60.0% | 25/48 | 1 |
Essential_Thrombocythemia.yaml |
52.2% | 62.0% | 24/46 | 1 |
Desmoplastic_Small_Round_Cell_Tumor.yaml |
52.3% | 60.9% | 23/44 | 1 |
Irritable_Bowel_Syndrome.yaml |
52.5% | 57.3% | 31/59 | 1 |
Clear_Cell_Renal_Cell_Carcinoma.yaml |
52.6% | 61.2% | 30/57 | 1 |
Small_Cell_Lung_Cancer.yaml |
52.7% | 60.8% | 39/74 | 1 |
Autoimmune_Hepatitis.yaml |
52.8% | 61.9% | 19/36 | |
Bipolar_Disorder.yaml |
52.8% | 62.1% | 28/53 | |
Polycythemia_Vera.yaml |
52.9% | 62.7% | 27/51 | 1 |
Pemphigus_Vulgaris.yaml |
53.1% | 60.2% | 17/32 | 1 |
Medullary_Thyroid_Carcinoma.yaml |
53.2% | 60.9% | 25/47 | 1 |
Duchenne_Muscular_Dystrophy.yaml |
53.5% | 59.9% | 23/43 | 1 |
Sjogrens_Syndrome.yaml |
53.8% | 61.9% | 21/39 | |
Thanatophoric_Dysplasia_Type_1.yaml |
54.1% | 64.5% | 20/37 | 1 |
BRAF_V600E_Mutant_NSCLC.yaml |
54.2% | 62.5% | 26/48 | 1 |
HER2_Positive_Breast_Cancer.yaml |
54.2% | 62.0% | 26/48 | 1 |
Major_Depressive_Disorder.yaml |
54.4% | 63.8% | 31/57 | |
Chronic_Myeloid_Leukemia.yaml |
54.4% | 62.3% | 43/79 | 1 |
Granulomatosis_with_Polyangiitis.yaml |
54.5% | 62.2% | 18/33 | |
Primary_Biliary_Cholangitis.yaml |
54.5% | 62.2% | 18/33 | |
Pulmonary_hypertension.yaml |
54.7% | 63.7% | 47/86 | 1 |
Phenylketonuria.yaml |
54.7% | 62.4% | 29/53 | 2 |
Polymyositis.yaml |
55.0% | 62.1% | 22/40 | 1 |
Dravet_syndrome.yaml |
55.3% | 65.0% | 42/76 | 1 |
Ewing_Sarcoma.yaml |
55.3% | 64.8% | 26/47 | 1 |
Von_Hippel-Lindau_Disease.yaml |
55.6% | 64.2% | 30/54 | |
Obesity.yaml |
55.8% | 63.6% | 43/77 | 1 |
Giant_Cell_Arteritis.yaml |
55.9% | 65.0% | 19/34 | |
Thanatophoric_Dysplasia_Type_2.yaml |
55.9% | 65.9% | 19/34 | 1 |
Coronary_Artery_Disease.yaml |
56.1% | 63.8% | 23/41 | |
Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml |
56.2% | 65.2% | 18/32 | |
Spinal_Muscular_Atrophy.yaml |
56.2% | 60.0% | 27/48 | 2 |
Sickle_Cell_Disease.yaml |
56.5% | 63.3% | 39/69 | |
MSI_High_Colorectal_Cancer.yaml |
56.9% | 64.5% | 33/58 | 1 |
Hepatitis_C.yaml |
57.1% | 66.3% | 28/49 | 1 |
Type_I_Diabetes.yaml |
57.1% | 63.6% | 76/133 | 5 |
Benign_Prostatic_Hyperplasia.yaml |
57.4% | 64.2% | 31/54 | 1 |
Primary_Sclerosing_Cholangitis.yaml |
57.6% | 64.9% | 19/33 | |
Camptodactyly.yaml |
57.9% | 64.9% | 33/57 | 1 |
NTRK_Fusion_Positive_Cancer.yaml |
57.9% | 63.6% | 22/38 | 1 |
Polycystic_Ovary_Syndrome.yaml |
58.1% | 64.3% | 25/43 | |
MSI_High_Endometrial_Cancer.yaml |
58.3% | 65.6% | 28/48 | 1 |
Retinoblastoma.yaml |
58.3% | 67.3% | 28/48 | 1 |
Adult_T_Cell_Leukemia_Lymphoma.yaml |
58.7% | 65.9% | 37/63 | 1 |
Immune_Thrombocytopenia.yaml |
58.8% | 68.0% | 20/34 | |
Osteogenesis_Imperfecta_Type_III.yaml |
58.8% | 69.5% | 20/34 | |
Alzheimers_Disease.yaml |
59.1% | 67.9% | 26/44 | |
BRAF_V600_Mutant_Melanoma.yaml |
59.1% | 66.9% | 26/44 | 1 |
Osteogenesis_Imperfecta_Type_VII.yaml |
59.4% | 68.6% | 19/32 | 1 |
Dermatomyositis.yaml |
59.5% | 67.2% | 22/37 | 1 |
Osteoporosis.yaml |
59.6% | 67.9% | 31/52 | |
Beta_Thalassemia.yaml |
60.0% | 71.7% | 66/110 | |
Down_syndrome.yaml |
60.4% | 68.7% | 32/53 | 1 |
Osteogenesis_Imperfecta_Type_IV.yaml |
60.7% | 70.6% | 17/28 | |
Hereditary_Spherocytosis.yaml |
60.8% | 68.9% | 45/74 | |
Bardet-Biedl_Syndrome.yaml |
61.2% | 64.7% | 63/103 | 2 |
Neuromyelitis_Optica.yaml |
61.2% | 61.5% | 30/49 | 5 |
Stargardt_Disease.yaml |
61.3% | 70.6% | 57/93 | |
Frontotemporal_Dementia.yaml |
61.5% | 65.7% | 24/39 | 2 |
Fibromyalgia.yaml |
62.3% | 71.0% | 48/77 | |
Atrial_Fibrillation.yaml |
62.7% | 69.8% | 37/59 | 1 |
Osteoarthritis.yaml |
62.8% | 70.4% | 27/43 | |
Crohn_Disease.yaml |
63.3% | 69.1% | 88/139 | 2 |
Osteogenesis_Imperfecta_Type_V.yaml |
63.3% | 73.0% | 19/30 | |
Triple_Negative_Breast_Cancer.yaml |
63.5% | 69.2% | 33/52 | 1 |
ATTR_Amyloidosis.yaml |
63.7% | 69.9% | 72/113 | 1 |
Costello_Syndrome.yaml |
65.0% | 74.4% | 26/40 | 1 |
Gorlin_Syndrome.yaml |
65.1% | 72.8% | 41/63 | 1 |
Osteogenesis_Imperfecta_Type_II.yaml |
65.4% | 73.4% | 17/26 | 1 |
Urea_Cycle_Disorder.yaml |
65.5% | 70.1% | 74/113 | 3 |
Mixed_Connective_Tissue_Disease.yaml |
65.7% | 73.4% | 23/35 | |
Marfan_Syndrome.yaml |
66.0% | 71.2% | 70/106 | 2 |
Type_2_Diabetes_Mellitus.yaml |
66.3% | 73.2% | 57/86 | 1 |
CTCF-related_Neurodevelopmental_Disorder.yaml |
66.7% | 74.7% | 48/72 | |
ER_Positive_Breast_Cancer.yaml |
66.7% | 73.0% | 34/51 | 1 |
Hemophilia_A.yaml |
66.7% | 71.7% | 22/33 | |
Ebola_Virus_Disease_EVD.yaml |
67.4% | 72.5% | 64/95 | 2 |
Rheumatoid_Arthritis.yaml |
67.4% | 72.3% | 89/132 | 2 |
Osteogenesis_Imperfecta_Type_I.yaml |
67.9% | 76.5% | 19/28 | |
Ehlers-Danlos_Syndrome.yaml |
67.9% | 72.6% | 72/106 | 1 |
Small_Intestinal_Bacterial_Overgrowth.yaml |
68.0% | 76.9% | 17/25 | |
Noonan_Syndrome.yaml |
68.9% | 76.1% | 73/106 | 1 |
Cardiofaciocutaneous_Syndrome.yaml |
69.0% | 77.9% | 29/42 | |
Beta_Mannosidosis.yaml |
69.2% | 77.4% | 18/26 | |
Kawasaki_Disease.yaml |
69.9% | 76.5% | 65/93 | |
Spondyloepiphyseal_Dysplasia_Congenita.yaml |
70.0% | 78.1% | 28/40 | 1 |
Kniest_Dysplasia.yaml |
70.3% | 78.6% | 26/37 | |
Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml |
70.3% | 78.9% | 26/37 | |
Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml |
70.4% | 78.6% | 19/27 | |
Achondroplasia.yaml |
70.5% | 78.4% | 31/44 | 1 |
Diamond-Blackfan_Anemia.yaml |
70.7% | 76.8% | 58/82 | |
Pouchitis.yaml |
71.1% | 79.5% | 27/38 | |
Gastric_Ulcer.yaml |
71.4% | 76.9% | 5/7 | |
Gaucher_Disease.yaml |
71.4% | 78.2% | 25/35 | |
Stickler_Syndrome_Type_1.yaml |
71.4% | 79.4% | 25/35 | |
Huntingtons_Disease.yaml |
71.6% | 77.6% | 68/95 | 1 |
Melanoma_in_Congenital_Melanocytic_Nevus.yaml |
71.6% | 76.6% | 48/67 | 1 |
Apert_Syndrome.yaml |
72.2% | 80.3% | 26/36 | |
Monkeypox.yaml |
72.5% | 77.2% | 79/109 | 2 |
Ehlers-Danlos_Syndrome_COL5A1-related.yaml |
72.6% | 78.2% | 53/73 | |
Fragile_X_Syndrome.yaml |
72.7% | 79.7% | 24/33 | |
Rett_Syndrome.yaml |
72.7% | 79.7% | 24/33 | |
Multiple_Synostoses_Syndrome.yaml |
73.3% | 80.0% | 22/30 | |
Primary_Ciliary_Dyskinesia.yaml |
73.6% | 79.6% | 67/91 | |
HIDEA_Syndrome.yaml |
74.1% | 80.8% | 40/54 | 2 |
Nephronophthisis.yaml |
74.4% | 78.7% | 67/90 | 1 |
Multiple_Sclerosis.yaml |
74.5% | 80.2% | 70/94 | |
Systemic_Lupus_Erythematosus.yaml |
74.8% | 79.4% | 104/139 | 2 |
Addisons_Disease.yaml |
75.0% | 79.6% | 75/100 | 2 |
Alpha_Thalassemia.yaml |
75.0% | 81.5% | 60/80 | |
Hypochondrogenesis.yaml |
75.0% | 82.9% | 21/28 | |
Scurvy.yaml |
75.0% | 80.9% | 21/28 | |
Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml |
75.7% | 81.3% | 87/115 | 1 |
Silent_Sinus_Syndrome.yaml |
76.0% | 81.5% | 19/25 | |
Alhzeimer_Disease.yaml |
76.1% | 77.8% | 86/113 | 3 |
Hypertensive_Heart_Disease.yaml |
76.3% | 80.9% | 71/93 | 2 |
Arsenic_Poisoning.yaml |
76.6% | 80.6% | 134/175 | 1 |
Klinefelter_Syndrome.yaml |
76.7% | 82.0% | 56/73 | 1 |
Citrin_Deficiency.yaml |
76.9% | 82.1% | 70/91 | 2 |
Crouzon_Syndrome.yaml |
76.9% | 84.0% | 20/26 | |
Achondrogenesis_Type_II.yaml |
77.1% | 84.0% | 27/35 | |
Shprintzen-Goldberg_Syndrome.yaml |
77.1% | 83.7% | 27/35 | |
Neuromyelitis_Optica_Spectrum_Disorder.yaml |
77.3% | 82.3% | 34/44 | 1 |
Dementia_with_Lewy_Bodies.yaml |
77.4% | 83.5% | 24/31 | |
Chronic_Pancreatitis.yaml |
77.8% | 81.2% | 35/45 | 1 |
Tay-Sachs_Disease.yaml |
77.8% | 83.7% | 35/45 | |
Urticaria.yaml |
77.8% | 87.0% | 7/9 | |
Peroxisome_Biogenesis_Disorder.yaml |
77.9% | 81.8% | 74/95 | 2 |
NELABA.yaml |
78.0% | 83.9% | 46/59 | |
Dieulafoy_Lesion.yaml |
78.1% | 82.7% | 25/32 | |
Pick_Disease.yaml |
78.3% | 82.3% | 54/69 | 2 |
Arginase_Deficiency.yaml |
78.5% | 83.9% | 62/79 | 1 |
Mitochondrial_Trifunctional_Protein_Deficiency.yaml |
78.5% | 82.4% | 73/93 | 2 |
Chronic_Obstructive_Pulmonary_Disease.yaml |
78.6% | 82.7% | 99/126 | 1 |
Pfeiffer_Syndrome.yaml |
78.6% | 85.4% | 22/28 | |
Temple-Baraitser_Syndrome.yaml |
78.6% | 84.2% | 81/103 | |
Transient_Neonatal_Pustular_Melanosis.yaml |
78.7% | 85.0% | 37/47 | |
Cholera.yaml |
78.8% | 82.1% | 108/137 | 1 |
Graves_Disease.yaml |
79.0% | 83.9% | 79/100 | 2 |
Holt-Oram_Syndrome.yaml |
79.2% | 85.4% | 19/24 | |
Schizophrenia.yaml |
79.2% | 81.4% | 61/77 | 2 |
Fibrodysplasia_Ossificans_Progressiva.yaml |
79.3% | 84.7% | 46/58 | |
CHIME_syndrome.yaml |
79.5% | 85.7% | 35/44 | |
Autosomal_Recessive_Osteopetrosis.yaml |
80.0% | 85.1% | 20/25 | 1 |
Asthma.yaml |
80.4% | 83.9% | 115/143 | 1 |
D-2-Hydroxyglutaric_Aciduria.yaml |
81.4% | 84.9% | 70/86 | 2 |
Familial_Mediterranean_Fever.yaml |
81.5% | 84.7% | 53/65 | 4 |
Hypertrophic_Cardiomyopathy.yaml |
81.7% | 85.8% | 76/93 | 1 |
Greig_Cephalopolysyndactyly.yaml |
81.8% | 87.7% | 18/22 | |
Camurati-Engelmann_Disease.yaml |
82.1% | 87.6% | 32/39 | |
Multiple_Acyl-CoA_Dehydrogenase_Deficiency.yaml |
82.3% | 86.1% | 79/96 | 1 |
Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml |
82.4% | 86.8% | 61/74 | |
Methylmalonic_Acidemia.yaml |
82.6% | 86.2% | 90/109 | 1 |
Morgagni-Stewart-Morel_Syndrome.yaml |
82.7% | 87.2% | 67/81 | |
Joubert_syndrome.yaml |
82.8% | 86.0% | 183/221 | |
Loeys-Dietz_Syndrome.yaml |
82.9% | 87.3% | 58/70 | |
Lyme_Disease.yaml |
82.9% | 87.3% | 63/76 | |
Tyrosinemia_Type_I.yaml |
82.9% | 87.2% | 63/76 | 1 |
Primary_Carnitine_Deficiency.yaml |
83.0% | 87.5% | 73/88 | 1 |
Narcolepsy.yaml |
83.0% | 87.6% | 39/47 | |
Pseudohypoparathyroidism.yaml |
83.1% | 87.2% | 64/77 | |
Essential_Hypertension.yaml |
83.3% | 88.3% | 35/42 | |
Pallister-Hall_Syndrome.yaml |
83.3% | 88.8% | 20/24 | |
Van_Buchem_Disease.yaml |
83.3% | 88.1% | 20/24 | 1 |
Vitiligo.yaml |
83.3% | 85.1% | 60/72 | 3 |
You-Hoover-Fong_Syndrome.yaml |
83.3% | 89.3% | 25/30 | |
N-Acetylglutamate_Synthase_Deficiency.yaml |
83.5% | 87.6% | 66/79 | 1 |
Non-Small_Cell_Lung_Cancer.yaml |
83.5% | 86.2% | 66/79 | 2 |
Antiphospholipid_Syndrome.yaml |
83.6% | 87.6% | 46/55 | |
Fanconi_Anemia.yaml |
83.7% | 87.2% | 477/570 | |
Netherton_Syndrome.yaml |
84.0% | 87.0% | 110/131 | |
Muenke_Syndrome.yaml |
84.0% | 89.9% | 21/25 | |
Nonketotic_Hyperglycinemia.yaml |
84.1% | 88.4% | 69/82 | |
22q11.2_Deletion_Syndrome.yaml |
84.2% | 88.9% | 48/57 | 1 |
3-Hydroxy-3-Methylglutaric_Aciduria.yaml |
84.3% | 88.4% | 75/89 | 1 |
Carbamoyl_Phosphate_Synthetase_I_Deficiency.yaml |
84.3% | 88.3% | 59/70 | 1 |
Hypophosphatasia.yaml |
84.4% | 89.7% | 27/32 | |
Acquired_Immunodeficiency_Syndrome.yaml |
84.5% | 88.2% | 60/71 | |
Jackson-Weiss_Syndrome.yaml |
84.6% | 90.4% | 22/26 | |
Keratoderma_Hereditarium_Mutilans.yaml |
84.6% | 89.0% | 44/52 | |
Hemochromatosis.yaml |
84.7% | 89.2% | 50/59 | |
Mucopolysaccharidosis.yaml |
85.3% | 90.2% | 29/34 | |
Cystic_Fibrosis.yaml |
85.4% | 88.8% | 169/198 | |
VLCAD_Deficiency.yaml |
85.4% | 89.2% | 88/103 | 1 |
Tuberculosis.yaml |
85.5% | 89.3% | 71/83 | 1 |
Dorsalgia.yaml |
85.7% | 100.0% | 6/7 | |
Holocarboxylase_Synthetase_Deficiency.yaml |
85.7% | 89.4% | 84/98 | 1 |
Lichen_Simplex_Chronicus.yaml |
85.7% | 100.0% | 6/7 | |
Mycetoma.yaml |
85.7% | 100.0% | 6/7 | |
Noma.yaml |
85.7% | 100.0% | 6/7 | |
Secondary_Hypertension.yaml |
85.7% | 100.0% | 6/7 | |
Labyrinthitis.yaml |
86.9% | 89.0% | 139/160 | 1 |
2-Methylbutyryl-CoA_Dehydrogenase_Deficiency.yaml |
87.0% | 90.2% | 60/69 | 1 |
Pycnodysostosis.yaml |
87.0% | 92.5% | 20/23 | |
Ulnar-Mammary_Syndrome.yaml |
87.0% | 92.3% | 20/23 | |
Parkinsons_Disease.yaml |
87.1% | 89.7% | 121/139 | |
Carnitine-Acylcarnitine_Translocase_Deficiency.yaml |
87.1% | 89.9% | 74/85 | 2 |
L-2-Hydroxyglutaric_Aciduria.yaml |
87.2% | 90.4% | 75/86 | 1 |
Autosomal_Dominant_Osteopetrosis_Type_II.yaml |
87.5% | 92.9% | 21/24 | |
Dracunculiasis.yaml |
87.5% | 100.0% | 7/8 | |
Parvovirus_B19_Infection.yaml |
87.5% | 89.7% | 49/56 | 1 |
Empty_Nose_Syndrome.yaml |
87.6% | 89.5% | 85/97 | 1 |
Aromatase_Deficiency.yaml |
87.7% | 91.7% | 57/65 | |
Congestive_Splenomegaly.yaml |
87.7% | 91.7% | 50/57 | |
Satoyoshi_Syndrome.yaml |
87.7% | 90.6% | 100/114 | 1 |
Beta-Ketothiolase_Deficiency.yaml |
87.8% | 91.2% | 72/82 | 1 |
Jeune_Asphyxiating_Thoracic_Dystrophy.yaml |
87.8% | 92.1% | 36/41 | |
Hand-Foot-Genital_Syndrome.yaml |
88.0% | 93.1% | 22/25 | |
Sclerosteosis.yaml |
88.0% | 93.1% | 22/25 | |
Argininosuccinic_Aciduria.yaml |
88.2% | 91.6% | 67/76 | 1 |
Ornithine_Carbamoyltransferase_Deficiency.yaml |
88.4% | 92.1% | 61/69 | |
Citrullinemia_Type_I.yaml |
88.6% | 92.0% | 70/79 | |
Brachydactyly_Type_A1.yaml |
88.9% | 94.8% | 16/18 | |
Colon_Adenocarcinoma.yaml |
88.9% | 87.9% | 16/18 | 1 |
Danon_disease.yaml |
88.9% | 93.3% | 40/45 | |
Malnutrition-related_Diabetes_Mellitus.yaml |
88.9% | 100.0% | 8/9 | |
Pinta.yaml |
88.9% | 100.0% | 8/9 | |
Prurigo_Nodularis.yaml |
88.9% | 100.0% | 8/9 | |
Isobutyryl-CoA_Dehydrogenase_Deficiency.yaml |
89.0% | 92.0% | 65/73 | 1 |
Carnitine_Palmitoyltransferase_II_Deficiency.yaml |
89.2% | 92.3% | 74/83 | |
Lipoyl_Transferase_1_Deficiency.yaml |
89.2% | 93.6% | 33/37 | |
Cadmium_Poisoning.yaml |
89.2% | 91.2% | 141/158 | 1 |
Propionic_Acidemia.yaml |
89.4% | 92.2% | 84/94 | 1 |
Hirschsprung_Disease.yaml |
89.5% | 92.7% | 51/57 | |
Menieres_Disease.yaml |
89.5% | 93.6% | 34/38 | |
Isovaleric_Acidemia.yaml |
89.7% | 92.7% | 70/78 | 1 |
Botulism.yaml |
90.0% | 100.0% | 9/10 | |
CADASIL_Type_1.yaml |
90.0% | 94.0% | 45/50 | |
Lipoic_Acid_Synthetase_Deficiency.yaml |
90.0% | 94.2% | 36/40 | |
Guanidinoacetate_Methyltransferase_Deficiency.yaml |
90.1% | 93.1% | 64/71 | 1 |
Alpha_1_Antitrypsin_Deficiency.yaml |
90.2% | 92.9% | 46/51 | 1 |
TARP_syndrome.yaml |
90.2% | 93.8% | 46/51 | |
SADDAN.yaml |
90.2% | 94.2% | 37/41 | |
Orofaciodigital_Syndrome_Type_I.yaml |
90.3% | 94.6% | 28/31 | |
Short-Rib_Polydactyly_Syndrome.yaml |
90.3% | 94.6% | 28/31 | |
Renal_Cell_Carcinoma.yaml |
90.5% | 89.9% | 19/21 | 1 |
Meckel_Syndrome.yaml |
90.6% | 92.9% | 125/138 | |
Amyotrophic_Lateral_Sclerosis.yaml |
90.7% | 92.6% | 97/107 | |
Hemophilia_B.yaml |
90.9% | 100.0% | 10/11 | |
Osteosarcoma.yaml |
90.9% | 90.9% | 20/22 | 1 |
Trachoma.yaml |
90.9% | 100.0% | 10/11 | |
Yaws.yaml |
90.9% | 100.0% | 10/11 | |
Kummell_Disease.yaml |
91.2% | 92.7% | 73/80 | 1 |
Migraine.yaml |
91.4% | 93.8% | 53/58 | |
Malaria.yaml |
91.5% | 92.5% | 107/117 | 1 |
Bejel.yaml |
91.7% | 100.0% | 11/12 | |
Breast_Fibroadenoma.yaml |
91.7% | 100.0% | 11/12 | |
Dengue.yaml |
91.7% | 100.0% | 11/12 | |
Infectious_Disease.yaml |
91.7% | 100.0% | 11/12 | |
CINCA_Syndrome.yaml |
91.7% | 93.2% | 122/133 | 1 |
Otomycosis.yaml |
91.8% | 92.4% | 67/73 | 2 |
Lymphoma.yaml |
92.0% | 92.0% | 23/25 | 1 |
Buruli_Ulcer.yaml |
92.3% | 100.0% | 12/13 | |
Chromoblastomycosis.yaml |
92.3% | 100.0% | 12/13 | |
Homocystinuria.yaml |
92.3% | 94.6% | 72/78 | 1 |
Taeniasis_Cysticercosis.yaml |
92.3% | 100.0% | 12/13 | |
Transverse_Myelitis.yaml |
92.3% | 94.4% | 36/39 | 1 |
Central_Core_Myopathy.yaml |
92.5% | 95.7% | 49/53 | |
Ellis-van_Creveld_Syndrome.yaml |
92.5% | 95.9% | 37/40 | |
Lung_Carcinoma.yaml |
92.6% | 92.4% | 25/27 | 1 |
Chagas_Disease.yaml |
92.9% | 100.0% | 13/14 | |
Cystic_Echinococcosis.yaml |
92.9% | 100.0% | 13/14 | |
Primary_Lateral_Sclerosis.yaml |
92.9% | 100.0% | 13/14 | |
Long-Chain_3-Hydroxyacyl-CoA_Dehydrogenase_Deficiency.yaml |
92.9% | 95.2% | 79/85 | 1 |
Chikungunya.yaml |
93.3% | 100.0% | 14/15 | |
Onchocerciasis.yaml |
93.3% | 100.0% | 14/15 | |
Polycystic_Kidney_Disease.yaml |
93.3% | 93.8% | 56/60 | 1 |
Primary_Progressive_Aphasia.yaml |
93.3% | 100.0% | 14/15 | |
Rabies.yaml |
93.3% | 100.0% | 14/15 | |
Chickenpox.yaml |
93.4% | 93.5% | 85/91 | 1 |
Raynaud_Disease.yaml |
93.5% | 98.7% | 58/62 | |
Human_African_Trypanosomiasis.yaml |
93.8% | 100.0% | 15/16 | |
Scabies.yaml |
93.8% | 100.0% | 15/16 | |
Semantic_Dementia.yaml |
93.8% | 100.0% | 15/16 | |
Snakebite_Envenoming.yaml |
93.8% | 100.0% | 15/16 | |
Stiff_Person_Syndrome.yaml |
93.9% | 96.7% | 46/49 | |
Cushings_Syndrome.yaml |
93.9% | 97.6% | 31/33 | |
Grange_syndrome.yaml |
93.9% | 97.5% | 31/33 | |
X-Linked_Hypophosphatemia.yaml |
93.9% | 97.6% | 31/33 | |
Tetanus.yaml |
94.0% | 94.2% | 47/50 | 1 |
Alcoholic_Liver_Disease.yaml |
94.1% | 92.7% | 16/17 | 1 |
Leprosy.yaml |
94.1% | 100.0% | 16/17 | |
Salla_Disease.yaml |
94.4% | 95.0% | 67/71 | 1 |
Psoriatic_Arthritis.yaml |
94.4% | 100.0% | 17/18 | |
Roifman-syndrome.yaml |
94.4% | 97.7% | 34/36 | |
Laryngotracheoesophageal_Cleft.yaml |
94.5% | 96.4% | 104/110 | |
Foodborne_Trematodiases.yaml |
94.7% | 100.0% | 18/19 | |
Leishmaniasis.yaml |
94.7% | 100.0% | 18/19 | |
Biotinidase_Deficiency.yaml |
94.8% | 97.0% | 73/77 | |
Hereditary_von_Willebrand_Disease.yaml |
95.0% | 100.0% | 19/20 | |
Schistosomiasis.yaml |
95.0% | 100.0% | 19/20 | |
Dientamoebiasis.yaml |
95.1% | 97.1% | 77/81 | |
Hepatitis_B.yaml |
95.1% | 96.6% | 77/81 | |
Shigellosis.yaml |
95.2% | 95.8% | 79/83 | 1 |
Soil_Transmitted_Helminthiases.yaml |
95.2% | 100.0% | 20/21 | |
Achoo_Syndrome.yaml |
95.5% | 98.1% | 42/44 | |
Meckel_Diverticulum.yaml |
95.5% | 100.0% | 21/22 | |
Glutaryl-CoA_Dehydrogenase_Deficiency.yaml |
95.5% | 97.3% | 85/89 | |
Travelers_Diarrhea.yaml |
95.9% | 98.3% | 47/49 | |
Lymphatic_Filariasis.yaml |
96.0% | 100.0% | 24/25 | |
Axenfeld-Rieger_syndrome.yaml |
96.1% | 97.8% | 49/51 | 1 |
Whipple_Disease.yaml |
96.4% | 98.6% | 53/55 | |
Jeavons_Syndrome.yaml |
96.5% | 98.5% | 55/57 | |
Retrograde_Cricopharyngeus_Dysfunction.yaml |
96.6% | 100.0% | 28/29 | |
Visual_Snow_Syndrome.yaml |
96.8% | 100.0% | 30/31 | |
Bacterial_meningitis.yaml |
96.9% | 98.2% | 127/131 | |
Ainhum.yaml |
97.0% | 100.0% | 32/33 | |
Polycystic_Echinococcosis.yaml |
97.1% | 100.0% | 33/34 | |
Auto-Brewery_Syndrome.yaml |
97.5% | 100.0% | 39/40 | |
Semicircular_Canal_Dehiscence_Syndrome.yaml |
97.5% | 100.0% | 39/40 | |
Bird_Fanciers_Lung.yaml |
97.6% | 97.5% | 120/123 | 1 |
Cronkhite-Canada_syndrome.yaml |
97.7% | 100.0% | 42/43 | |
Wolf-Hirschhorn_Syndrome.yaml |
97.9% | 100.0% | 46/47 | |
FICUS_syndrome.yaml |
97.9% | 100.0% | 47/48 | |
Holt_Oram.yaml |
98.0% | 100.0% | 48/49 | |
Wissler_syndrome.yaml |
98.0% | 100.0% | 48/49 | |
Peutz_Jeghers_polyp.yaml |
98.0% | 100.0% | 50/51 | |
Wilsons_Disease.yaml |
98.1% | 98.3% | 103/105 | 1 |
Acne_Vulgaris.yaml |
98.1% | 98.6% | 157/160 | |
Lane_Hamilton_Syndrome.yaml |
98.1% | 100.0% | 53/54 | |
Akinetopsia.yaml |
98.2% | 100.0% | 55/56 | |
Melkersson_Rosenthal_syndrome.yaml |
98.4% | 100.0% | 60/61 | |
Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml |
98.4% | 100.0% | 60/61 | |
Refeeding_Syndrome.yaml |
98.4% | 100.0% | 61/62 | |
Fabry_Disease.yaml |
98.5% | 100.0% | 65/66 | |
Ludwigs_Angina.yaml |
98.6% | 100.0% | 68/69 | |
Maple_Syrup_Urine_Disease.yaml |
98.6% | 100.0% | 70/71 | |
Sengers_syndrome.yaml |
98.6% | 100.0% | 71/72 | |
Furunculosis.yaml |
98.7% | 100.0% | 76/77 | |
Scimitar_Syndrome.yaml |
98.7% | 99.0% | 76/77 | |
Collagenous_Sprue.yaml |
98.7% | 100.0% | 78/79 | |
Cogan_Syndrome.yaml |
98.8% | 100.0% | 79/80 | |
Houge-Janssens_Syndrome.yaml |
98.8% | 100.0% | 80/81 | |
Pars_Planitis.yaml |
98.9% | 100.0% | 88/89 | |
Proteus_syndrome.yaml |
98.9% | 100.0% | 91/92 | |
Campylobacteriosis.yaml |
100.0% | 100.0% | 96/96 | |
Clostridioides_difficile_Infection.yaml |
100.0% | 100.0% | 102/102 | |
Long_COVID.yaml |
100.0% | 100.0% | 106/106 | |
Lynch_Syndrome.yaml |
100.0% | 100.0% | 97/97 | |
Taurodontism.yaml |
100.0% | 100.0% | 89/89 |
Not Yet Curated Disease Links
Found 227 referenced MONDO disease terms without local pages across 235 linking page references.